Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
March 28, 2024
For those of us who have long been pressing for more access to data from the Global Emerging Markets (GEMs) Risk Database (here and here), the publication this week of a report on MDB loan recovery statistics is welcome validation of the market-building importance of these data and an important step...
Blog Post
March 27, 2024
Today marks a significant milestone as the Bill & Melinda Gates Foundation (BMGF) announces a new Open Access policy, representing a departure from traditional practices. This policy will cease support for individual article publishing fees, known as APCs, and mandate the use of preprints while advo...
Blog Post
March 18, 2024
Today, Dr. Sania Nishtar assumes her role as Gavi's new CEO. A lot has changed—both within Gavi and in the external environment—since the process began to replace Dr. Seth Berkley, who stepped down last year. Dr. Nishtar’s appointment comes at a critical time for Gavi. As CEO, Dr. Nishtar will play ...
Blog Post
March 14, 2024
Since its inception, DFC has demonstrated its capacity to rapidly increase its investment volume, making use of a higher portfolio cap. Its annual commitments have doubled over the past four years. But the agency has been subject to criticism (including from some at CGD) for insufficiently prioritiz...
Blog Post
March 11, 2024
The African Development Bank has been a prime mover in advancing a new form of capital for the multilateral development banks, called hybrid capital. If there is another item on the MDB reform agenda that is more of a win-win proposition than hybrid capital, we are not aware of it.
Blog Post
March 11, 2024
Last month, Open Philanthropy published a list of open research questions they would like answers to. It’s a fascinating list, and in keeping with their mission, focuses on some potentially high-impact and neglected problems where more evidence could make a big difference to improve social and econo...
Blog Post
March 08, 2024
For nearly 25 years, innovation has been core to Gavi’s success in accelerating vaccine introductions in lower-income countries. Building on this track record, Gavi has a high-impact opportunity to sharpen its focus on scaling innovations for systems improvement in its next five-year strategic perio...